Omeros Corporation
OMERBiotechnology
$18.95+5.98%As of Oct 29vs prior close
- Market cap
- $1.4B
- From 52W high
- −9.98%
- EPS (LTM)
- $1.73
- Revenue (YE20)
- $73.8M
- Dividend yield
- 0.00%
Nomior Score
53
Steady ProfileTop 44% of the scored universe
Growth63
Quality35
Value—
Momentum85
Resilience29
Growth
+15.40%revenue a year over 4 fiscal years
YE16 $41.6MYE20 $73.8M
Connections
Revenue to profitQ2 YE26
46% of revenue became net profit.
Who owns it
2funds